‘Recognising the critical importance to world health of the rapid availability and deployment of effective vaccines against COVID-19, this large, international, multi-site, individually randomised controlled clinical trial will enable the concurrent evaluation of the benefits and risks of each promising candidate vaccine within 3-6 months of it being made available for the trial.
‘Its goal is to “coordinate evaluation of the many preventive candidate SARS CoV-2 vaccines under development, to evaluate promptly, efficiently and reliably their safety and efficacy, enabling assessment of whether any are appropriate for deployment to influence the course of the pandemic”.’
Read here (WHO, April 9, 2020)
